Picture of TransMedics logo

TMDX — TransMedics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Transmedics Group Inc expected to post earnings of 21 cents a share - Earnings Preview

* Transmedics Group Inc  TMDX.OQ   TMDX.O  is expected
to show a
rise in quarterly revenue when it reports  results on July 31
for the period ending June 30 2024
    * The Andover Massachusetts-based  company is expected to
report a
88.6% increase in revenue to $98.969 million from $52.47 million
a year ago, according to the mean estimate from 8 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Transmedics Group Inc is
for
earnings of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Transmedics
Group
Inc is $151.00​, above​ its last closing price of $139.00. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.04       -0.04      0.35      Beat    975
 Dec. 31 2024  -0.03       -0.06      0.12      Beat    293.5
 Sep. 30 2023  -0.16       -0.16      -0.78     Missed  -382.5
                                                        ​
 Jun. 30 2023  -0.11       -0.13      -0.03     Beat    76.9
 ​​Mar.        -0.21       -0.25      -0.08     Beat    67.5
 31 2023                                                
 Dec. 31 2022  -0.30       -0.30      -0.21     Beat    30​
 Sep. 30 2022  -0.43       -0.41      -0.25     Beat    39.3
 Jun. 30 2022  -0.35       -0.35      -0.41     Missed  -17.8
 This summary was machine generated July 29 at 22:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on TransMedics

See all news